Prophylactic supraclavicular lymph node dissection for esophageal squamous cell carcinoma: a systematic review and meta-analysis

[1]  K. Matsushima,et al.  Three-field versus two-field lymphadenectomy for esophageal squamous cell carcinoma: A long-term survival meta-analysis. , 2021, Surgery.

[2]  S. Tsunoda,et al.  Parallel-group controlled trial of surgery versus chemoradiotherapy in patients with stage I esophageal squamous cell carcinoma. , 2021, Gastroenterology.

[3]  Yang Zhang,et al.  Esophagectomy with three-field versus two-field lymphadenectomy for middle and lower thoracic esophageal cancer: Long-term outcomes of a randomized clinical trial. , 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[4]  Yang Yang,et al.  Three-Field versus Two-Field Lymphadenectomy for Esophageal Squamous Cell Carcinoma: A Meta-Analysis. , 2020, The Journal of surgical research.

[5]  J. Wang,et al.  Three‐field versus two‐field lymphadenectomy in transthoracic oesophagectomy for oesophageal squamous cell carcinoma: short‐term outcomes of a randomized clinical trial , 2020, The British journal of surgery.

[6]  S. Tsunoda,et al.  Mesenteric excision of upper esophagus: a concept for rational anatomical lymphadenectomy of the recurrent laryngeal nodes in thoracoscopic esophagectomy , 2020, Surgical Endoscopy.

[7]  Quan P. Ly,et al.  Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. , 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

[8]  Y. Kakeji,et al.  Prophylactic Cervical Lymph Node Dissection in Thoracoscopic Esophagectomy for Esophageal Cancer Increases Postoperative Complications and Does Not Improve Survival , 2019, Annals of Surgical Oncology.

[9]  Masahiro Yoshida,et al.  Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2 , 2018, Esophagus.

[10]  Masahiro Yoshida,et al.  Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1 , 2018, Esophagus.

[11]  K. Kumagai,et al.  Oesophagectomy with or without supraclavicular lymphadenectomy after neoadjuvant treatment for squamous cell carcinoma of the oesophagus , 2018, The British journal of surgery.

[12]  Y. Doki,et al.  Comparison of short-term outcomes between 2- and 3-field lymph node dissection for esophageal cancer. , 2017, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[13]  Japan Esophageal Society.  Japanese Classification of Esophageal Cancer, 11th Edition: part I , 2016, Esophagus.

[14]  Y. Tachimori,et al.  Efficacy of lymph node dissection for each station based on esophageal tumor location , 2016, Esophagus.

[15]  Lan-Jun Zhang,et al.  Three-field vs two-field lymph node dissection for esophageal cancer: a meta-analysis. , 2014, World journal of gastroenterology.

[16]  Y. Tachimori,et al.  Supraclavicular node metastasis from thoracic esophageal carcinoma: A surgical series from a Japanese multi-institutional nationwide registry of esophageal cancer. , 2014, The Journal of thoracic and cardiovascular surgery.

[17]  Yang Zhang,et al.  Three-field or two-field resection for thoracic esophageal cancer: a meta-analysis. , 2013, The Annals of thoracic surgery.

[18]  M. Ueno,et al.  The importance of grouping of lymph node stations and rationale of three‐field lymphoadenectomy for thoracic esophageal cancer , 2012, Journal of surgical oncology.

[19]  H. Eguchi,et al.  Prognosis of patients who develop cervical lymph node recurrence following curative resection for thoracic esophageal cancer. , 2006, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[20]  S. Law,et al.  Two-field dissection is enough for esophageal cancer. , 2001, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[21]  Y. Kitagawa,et al.  Improvement in the Results of Surgical Treatment of Advanced Squamous Esophageal Carcinoma During 15 Consecutive Years , 2000, Annals of surgery.

[22]  Y. Kajiyama,et al.  Radical Lymph Node Dissection for Cancer of the Thoracic Esophagus , 1994, Annals of surgery.

[23]  K. Okuyama,et al.  The treatment of lymph node metastasis from esophageal cancer by extensive lymphadenectomy , 1990, The Japanese journal of surgery.

[24]  K. Haustermans,et al.  Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[25]  W. Guo,et al.  Salvage Lymphadenectomy Versus Salvage Radiotherapy/Chemoradiotherapy for Recurrence in Cervical Lymph Node After Curative Resection of Esophageal Squamous Cell Carcinoma , 2014, Annals of Surgical Oncology.

[26]  Leslie H. Sobin,et al.  TNM Classification of Malignant Tumours, 7th Edition , 2009 .

[27]  T. Nishihira,et al.  A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus. , 1998, American journal of surgery.

[28]  H. Kato.  Lymph node dissection for thoracic esophageal carcinoma. Two- and 3-field lymph node dissection. , 1995, Annales chirurgiae et gynaecologiae.

[29]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.